The changing regulatory landscape for influenza vaccines

• Changes in EU guidance, annual update studies and new requirements for BRIC countries
• The rise of adjuvants and pre-pandemic vaccines
• Looking forward – what changes, both regulatory and scientific, will the next decade bring?

Ed Geuns

Ed Geuns is Director Regulatory Affairs, Vaccines, at Abbott Biologicals B.V. in Weesp, the Netherlands. He was awarded a MSc degree in pharmacy by the University of Leiden and a PharmD degree by...

more..